Tanya Aneichyk·Jan 5Why Biopharma AI Adoption ROI Takes Years — and Why Most Pilots FailMany don’t know this, but before joining biopharma R&D I developed AI systems for operations research(OR) — production planning, routing…A response icon1A response icon1
Tanya Aneichyk·Dec 5, 2025Practical guide to migration (including to/from the US)With the current political situation in the US, many are considering emigration, but understandably it’s a scary process for someone who…A response icon1A response icon1
Tanya Aneichyk·Dec 2, 2025Can you call your biotech pipeline “AI-driven”?And what it takes to be able to do that!
Tanya Aneichyk·Nov 11, 2025The Two Faces of Data Analysis in Biotech: Speed vs StructureThere are two ways you can do data analysis — quick and dirty or systemic and well-documented. Both ways may lead to exactly the same…
Tanya Aneichyk·Oct 22, 2025Data in Clinical Cancer Research: ESMO perspectiveThis year at ESMO, while everyone else was looking for breakthroughs in cancer care, I was on the lookout for new datasets.
Tanya Aneichyk·Oct 22, 2025The downfall of drug discovery biotech GalapagosIn 2023 Damian Garde from STAT described Galapagos as “the worst investment in Biotech”.A response icon1A response icon1
Tanya Aneichyk·Oct 13, 2025Why your investment in self-service bioinformatics software was a mistake and where to invest next…In 2020, in my post about commercialization in bioinformatics, I argued that bioinformatics’ academic roots and open-source academic…
Tanya Aneichyk·Oct 6, 2025How to build data strategy in experiment-first biopharma organizationBiopharma executives tell me versions of the same story. One client conceded:
Tanya Aneichyk·Sep 24, 2025The Secret Life of NA in Biotech DatasetsHow biological instruments use NA to encode signals and Zeros to encode NA